To our knowledge, this is the first study reporting the upregulation of KNG1 in MDA-MB-231 after NVA-AA NP treatment, representing it as a promising therapeutic target for inhibiting cancer invasion and metastasis. The gene discussed is KNG1; the disease is cancer.